Bausch Health Companies Inc BHC

NYS: BHC | ISIN: CA0717341071   20/03/2026
5,010 USD (-0,40%)
(-0,40%)   20/03/2026

23 februari 2026 · Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada · Persbericht

19 februari 2026 · Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres · Persbericht

18 februari 2026 · Bausch Health Announces Fourth Quarter And Full-Year 2025 Results · Persbericht

17 februari 2026 · Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference · Persbericht

11 februari 2026 · Bausch Health Announces 2026 Gastrointestinal Health Scholars Program · Persbericht

23 januari 2026 · Bausch Health Provides Update on RED-C Phase 3 Clinical Trials · Persbericht

21 januari 2026 · Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 · Persbericht

5 januari 2026 · Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference · Persbericht

11 september 2025 · Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio · Persbericht

29 juli 2025 · Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease · Persbericht

5 oktober 2023 · Thinking about trading options or stock in Tesla, Palantir Technologies, Bausch Health Companies, Alphabet Inc, or Shell? · Persbericht

26 september 2023 · SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Bausch Health Companies Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 25, 2023 - (NYSE: BHC) · Persbericht

10 september 2023 · Bausch Health Companies Inc. (BHC) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf · Persbericht

8 september 2023 · BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit · Persbericht

2 september 2023 · Kessler Topaz Meltzer & Check, LLP Reminds BHC Investors of September 25, 2023 Deadline in Securities Fraud Class Action against of Bausch Health Companies Inc. and Urges Investors with Substantial Losses to Contact the Firm · Persbericht

25 augustus 2023 · BHC Investors Have Opportunity to Lead Bausch Health Companies Inc. Securities Fraud Lawsuit · Persbericht

24 augustus 2023 · Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm · Persbericht

14 augustus 2023 · Bausch Health Companies Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Bausch Health Companies Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit · Persbericht

12 augustus 2023 · BHC INVESTOR NOTICE: Bausch Health Companies Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit · Persbericht

6 augustus 2023 · BHC CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Bausch Health Companies Inc. (BHC) · Persbericht

Mijn selecties